Investigating High-risk Factors, Precise Diagnosis, and Treatment of Castration-Resistant Prostate Cancer (CRPC).

Ma, Yuan; Liu, Zihao; Yu, Wenyue; Huang, Hua; Wang, Yong; Niu, Yuanjie

Ma, Yuan; Liu, Zihao; Yu, Wenyue; Huang, Hua; Wang, Yong; Niu, Yuanjie.

Afiliación

Ma Y; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Liu Z; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Yu W; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Huang H; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Wang Y; Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Niu Y; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.

Comb Chem High Throughput Screen ; 2023 Nov 21.

Article en En | MEDLINE | ID: mdl-37990901

Palabras clave

Prostate cancer; biopsy principle; castration-resistant prostate cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Comb Chem High Throughput Screen Asunto de la revista: BIOLOGIA MOLECULAR / QUIMICA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google